Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Dose-Finding Study of Paclitaxel Oral Solution in Neoadjuvant Therapy for Patients With Triple Negative Breast Cancer

NCT07739485 is registered in ClinicalTrials.gov with Liu Shu as lead sponsor.

NCT NCT07739485
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07739485 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Dose-Finding Study of Paclitaxel Oral Solution in Neoadjuvant Therapy for Patients With Triple Negative Breast Cancer
Lead sponsor
Liu Shu
Phase
Phase 1/2
Overall status
Recruiting
Start date
July 30, 2026
Completion date
July 30, 2029
Enrollment
30 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

triple -negative breast cancer